News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
PharmAlliance's Acquisition of CHEORS Marks a Strategic Step Forward in Pharmaceutical Expansion
Tuesday, April 16, 2024PharmAlliance a prominent pharmaceutical and life sciences services platform is thrilled to announce its latest acquisition of Complete Health Economics Outcomes Research Solutions
BioSyent Extends Agreement for RepaGyn® and Proktis-M®
Monday, April 15, 2024BioSyent Inc is excited to announce that its subsidiary BioSyent Pharma Inc has prolonged its Exclusive License and Distribution Agreement with its European partner for the RepaGyn and ProktisM products granting exclusive Canadian rights
Modalis Enters Partnership with Ginkgo Bioworks
Saturday, April 13, 2024Modalis Therapeutics Corporation has recently entered into a collaboration with Ginkgo Bioworks to join the Ginkgo Technology Network This partnership aims to provide Ginkgos global clientele in the cell and gene therapy sectors access
Candel Therapeutics Secures FDA Orphan Drug Designation for CAN-2409 Targeting Pancreatic Cancer
Friday, April 12, 2024Candel Therapeutics Inc publicly traded under the symbol CADL on the Nasdaq has been granted Orphan Drug Designation by the US Food and Drug Administration for its leading candidate
TR1X Receives FDA Approval for TRX103: Allogeneic Regulatory T-Cell Therapy Targeting Autoimmune Diseases
Thursday, April 11, 2024TrX Inc a company focusing on autoimmune and inflammatory disease treatments has received FDA approval for its Investigational New Drug application for TRX This drug aims to prevent Graft versus
Shorla Oncology Receives FDA Acceptance for New Drug Application Targeting Specific Forms of Leukemia and Other Cancers
Wednesday, April 10, 2024Shorla Oncology a specialty pharmaceutical company headquartered in both the United States and Ireland has made a significant announcement today The US Food and Drug Administration
Model Medicines Announces Breakthroughs in AI-Driven Drug Discovery: Two New Preprint Papers Showcase Innovations in Novel Chemistry and Biology
Wednesday, April 10, 2024Model Medicines a prominent company in the field of human health specializing in AIdriven drug discovery has released two significant preprint papers on bioRxiv outlining major advancements
Vivet Therapeutics Administers First Patient Dose in Cohort 2 of Phase 1/2 GATEWAY Clinical Trial for Wilson Disease Treatment
Tuesday, April 09, 2024Vivet Therapeutics has achieved a significant milestone in its effort to address Wilson Disease a rare inherited liver metabolic disorder characterized by the accumulation of toxic copper levels
AustinPx Boosts Drug Development Through Investments in Pharmaceutics and Manufacturing
Monday, April 08, 2024AustinPx a prominent contract development and manufacturing organization specializing in enhancing the bioavailability of orally administered small molecule drug candidates has recently acquired advanced
Aethon Therapeutics Enters Collaboration with Revolution Medicines to Explore and Develop Innovative Antibody Programs
Friday, April 05, 2024Aethon Therapeutics a biotechnology company has partnered with Revolution Medicines Inc a clinicalstage oncology company to collaborate on novel antibody therapeutics for cancer treatment
